VANI — Vivani Medical, Inc.
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1266806 ·
Last close
$1.05
Market Cap
$94.71M
52W High
$1.66
52W Low
$0.80
ADV30
250,795
Next earnings
2026-11-12
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 0 | — | -7,532,000 | -7,250,000 | 35,310,000 | 14,591,000 | 22,092,000 |
| Jun 2026 | 0 | — | -6,874,000 | -6,370,000 | 41,639,000 | 19,894,000 | 22,672,000 |
| Mar 2026 | 0 | — | -6,817,000 | -6,780,000 | 42,353,000 | 19,749,000 | 23,268,000 |
| Dec 2025 | 0 | — | -6,810,000 | -6,633,000 | 39,393,000 | 16,232,000 | 23,663,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-25,340,000
Investing CF
$-376,000
Financing CF
$37,225,000
CapEx
$-1,199,000
Dividends Paid
—
Buybacks
$0
EPS Diluted TTM
$-0.34
As of
2026-11-15
Balance + Analyst (yfinance extras)
Retained Earnings
$-168,933,000
Inventory
—
Receivables
$305,000
ST Investments
—
EBIT TTM
$-28,033,000
Pretax Income TTM
$-27,033,000
Interest Exp TTM
—
Analysts
3
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -27,556,000 | -26,609,000 | 39,393,000 | 23,663,000 | 15,730,000 | -24,320,000 |
| Dec 2024 | 0 | -24,677,000 | -23,486,000 | 41,561,000 | 23,951,000 | 17,610,000 | -20,786,000 |
| Dec 2023 | 0 | -26,965,000 | -25,652,000 | 45,797,000 | 25,036,000 | 20,761,000 | -23,699,000 |
| Dec 2022 | 0 | -21,241,000 | -13,889,000 | 51,130,000 | 6,822,000 | 44,308,000 | -18,787,000 |
TTM Snapshot
Revenues TTM
$0
NetIncome TTM
$-26,313,000
OpCashFlow TTM
—
Assets (Latest)
$41,639,000
Forward EPS
$-0.35
Max Pain — expiry 2027-02-19
max pain strike: $1.00 · spot: $1.05 · call oi: 1,513 · put oi: 2
Expected Move to 2027-02-19:
±$0.48
(45.71%) —
implied range
$0.57 –
$1.53
· ATM straddle on $1.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| NYXH | Nyxoah SA | $91.65M | $0.90 | — |
| SKIN | SkinHealth Systems Inc. | $90.40M | $13.88 | — |
| STIM | Neuronetics, Inc. | $99.49M | $1.28 | — |
| STXS | Stereotaxis, Inc. | $88.39M | $0.88 | — |
| APYX | Apyx Medical Corp | $107.63M | $2.56 | — |
News headlines (Yahoo Finance, 1h cache)
Vivani Medical Announces Private Placement Equity Financing
2026-11-16 10:30 · Yahoo
Vivani Medical Announces Positive Top-Line Results from SLIM-1™, a First in Human Phase 1 Trial of NPM-139 (semaglutide implant) and Wegovy (weekly semaglutide injections) in Obese and Overweight Subj
2026-11-12 13:00 · Yahoo
Vivani Medical: Q3 Earnings Snapshot
2026-11-11 21:20 · Yahoo
Vivani Medical Reports Third Quarter 2026 Financial Results and Provides Business Update
2026-11-11 21:05 · Yahoo
Vivani Medical Announces Participation in Upcoming Investor Conferences
2026-10-12 11:00 · Yahoo
Vivani Medical Announces Successful Dosing of All Participants in SLIM-1, a Phase 1 Trial Evaluating NPM-139, a Miniature, Ultra Long-Acting Semaglutide Implant for Chronic Weight Management
2026-08-06 12:00 · Yahoo
Vivani Medical Eyes August Human Trial for Semaglutide Implant After Novo Nordisk Deal
2026-07-15 23:02 · Yahoo
Vivani Medical to Present at the Emerging Growth Conference on July 15, 2026
2026-07-14 20:03 · Yahoo
Novo Nordisk signs pact with Vivani for long-lasting semaglutide implant
2026-07-08 11:11 · Yahoo
Vivani Medical Enters into Agreement with Novo Nordisk to Evaluate NPM-139, a Miniature, Ultra Long-Acting Semaglutide Implant for Chronic Weight Management
2026-07-07 11:35 · Yahoo
Recent Insider Activity
| Filed | Trade | Insider | Title | Type | Price | Qty | Value |
|---|---|---|---|---|---|---|---|
| 2026-11-16 8:00:18 | 2026-11-13 | Williams Gregg | Dir, 10% | P - Purchase | 0.99 | 48100 | 47763 |